- Home
- ALXO vs ELBM Comparison
ALXO vs ELBM Comparison
Compare ALXO & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- ELBM
- Stock Information
- Founded
- ALXO 2015
- ELBM 2011
- Country
- ALXO United States
- ELBM Canada
- Employees
- ALXO N/A
- ELBM N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- ELBM Industrial Machinery/Components
- Sector
- ALXO Health Care
- ELBM Miscellaneous
- Exchange
- ALXO Nasdaq
- ELBM Nasdaq
- Market Cap
- ALXO 24.0M
- ELBM 23.2M
- IPO Year
- ALXO 2020
- ELBM N/A
- Fundamental
- Price
- ALXO $0.60
- ELBM $1.23
- Analyst Decision
- ALXO Strong Buy
- ELBM Strong Buy
- Analyst Count
- ALXO 6
- ELBM 1
- Target Price
- ALXO $3.30
- ELBM $2.20
- AVG Volume (30 Days)
- ALXO 494.7K
- ELBM 129.3K
- Earning Date
- ALXO 08-07-2025
- ELBM 08-13-2025
- Dividend Yield
- ALXO N/A
- ELBM N/A
- EPS Growth
- ALXO N/A
- ELBM N/A
- EPS
- ALXO N/A
- ELBM N/A
- Revenue
- ALXO N/A
- ELBM N/A
- Revenue This Year
- ALXO N/A
- ELBM N/A
- Revenue Next Year
- ALXO N/A
- ELBM N/A
- P/E Ratio
- ALXO N/A
- ELBM N/A
- Revenue Growth
- ALXO N/A
- ELBM N/A
- 52 Week Low
- ALXO $0.40
- ELBM $0.91
- 52 Week High
- ALXO $6.08
- ELBM $2.83
- Technical
- Relative Strength Index (RSI)
- ALXO 63.55
- ELBM 56.69
- Support Level
- ALXO $0.44
- ELBM $1.13
- Resistance Level
- ALXO $0.64
- ELBM $1.31
- Average True Range (ATR)
- ALXO 0.04
- ELBM 0.06
- MACD
- ALXO 0.02
- ELBM 0.00
- Stochastic Oscillator
- ALXO 76.35
- ELBM 53.40
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.